检索

期
标题
作者
卷 28, 编号 3 (2021)
Drug-induced atrial fibrillation/flutter associated with drugs affecting the central nervous system
Ostroumova O., Cherniaeva M., Maslennikova O., Zykova O., Komarova A., Sychev D.
PDF
(Rus)
卷 31, 编号 6 (2024)
The use of propafenone in the treatment of atrial fibrillation
Syrov A.
PDF
(Rus)
卷 31, 编号 2 (2024)
Metformin prevents the development of atrial fibrillation
Leonova M.
PDF
(Rus)
卷 32, 编号 1 (2025)
Anticoagulant therapy in elderly patients with atrial fibrillation and atrial flutter: the position of rivaroxaban
Zakiev V.
PDF
(Rus)
卷 30, 编号 1/2 (2023)
Modern principles of antiarrhythmic therapy of atrial fibrillation
Tarzimanova A.
PDF
(Rus)
卷 26, 编号 9 (2019)
QRS complex fragmentation in ST-segment elevation myocardial infarction: a clinical case
Gordeev I., Volov N., Arefiev M., Ilchenko R.
PDF
(Rus)
编号 6 (2014)
Sovremennye vozmozhnosti profilaktiki insul'tov u bol'nykh fibrillyatsiey predserdiy
Baryshnikova G.
PDF
(Rus)
编号 14 (2011)
ATRIAL FIBRILLATION ASSOCIATED WITH ARTERIAL HYPERTENSION
Volkov V., Volkov V.
卷 31, 编号 7 (2024)
Modern methods of thrombosis prevention and treatment in cancer patients with atrial fibrillation: focus on apixaban
Rubanenko O., Zolotovskaya I., Shatskaya P.
PDF
(Rus)
卷 31, 编号 1 (2024)
State of cognitive functions in patients with various forms of atrial fibrillation
Orlova I., Batyukina S., Kochetkov A., Piksina G., Plotnikova N., Ostroumova O.
PDF
(Rus)
卷 30, 编号 1/2 (2023)
Atrial fibrillation and anemia: what do we know and how to approach therapy?
Polyakova O., Dubinina A., Telkova S., Isaakyan Y., Ostroumova O.
PDF
(Rus)
卷 26, 编号 3 (2019)
Prediction of the probability of hemorrhagic transformation to clarify the possible timing of initiation of anticoagulant therapy in patients with ischemic stroke and atrial fibrillation
Kalinin M.
PDF
(Rus)
编号 18 (2013)
Individualizirovannaya antitromboticheskaya terapiya pri fibrillyatsii predserdiy
Ashikhmin Y., Shchekochikhin D.
PDF
(Rus)
编号 20 (2009)
Dinamika pokazateley variabel'nosti ritma serdtsa na fone terapii sotalolom i verapamilom u bol'nykh arterial'noy gipertenziey s paroksizmami fibrillyatsii predserdiy
Sbrodova L., Volkov V., Pshenitsin A., Kostoeva A., Mazur N.
卷 31, 编号 6 (2024)
On the possible relationship between polymorphic variants of the CYP2C19 gene, residual concentration and the presence of bleeding in patients who have suffered acute coronary syndrome and are receiving clopidogrel as part of dual antithrombotic therapy
De V., Kochetkov A., Abdullaev S., Bochkov P., Klepikova M., Batyukina S., Mirzaev K., Ostroumova O.
PDF
(Rus)
卷 31, 编号 1 (2024)
On the possible relationship between the presence of polymorphic variants of CYP3A4/5 cytochrome genes, their metabolic activity with rivaroxaban pharmacokinetics and the development of bleeding in patients with non-valvular atrial fibrillation and chronic kidney disease
Shatalova N., Mirzaev K., Abdullaev S., Sozaeva Z., Bochkov P., Asoskova A., Denisenko N., Kochetkov A., Ebzeeva E., Chernyaeva M., Shastina V., Ostroumova O., Sychev D.
PDF
(Rus)
卷 29, 编号 11/12 (2022)
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A., Prikolota O., Prikolota A., Mikhailichenko E., Golodnikov I., Bagriy O., Kotova K.
PDF
(Rus)
编号 9 (2017)
RISK FACTORS FOR CEREBROVASCULAR DISEASES IN NEUROGERIATRY
Novikova L., Akopyan A., Mustafin K., Khabibrakhmanova N., Kayumova I.
PDF
(Rus)
编号 13 (2013)
Profilaktika tromboembolicheskikh oslozhneniy u patsientov s khronicheskoy serdechnoy nedostatochnost'yu
Napalkov D., Sokolova A., Zhilenko A.
PDF
(Rus)
编号 11 (2009)
Antihypertensive therapy in patients with paroxysmal form of atrial fibrillation: is drug selection important?
Romanova E., Kirichenko A., Romanova E., Kirichenko A.
卷 31, 编号 6 (2024)
Antiarrhythmic effects of sodium-glucose cotransporter-2 inhibitors: a review of studies and mechanisms of action
Leonova M.
PDF
(Rus)
卷 30, 编号 14 (2023)
Analysis of the structure of comorbidities and pharmacotherapy in patients with a combination of atrial fibrillation and coronary heart disease
Dubinina A., Kochetkov A., Vorobieva А., Eremina S., Mirzaev K., Ostroumova O.
PDF
(Rus)
卷 29, 编号 3 (2022)
Features of the management and follow-up of a "difficult" comorbid elderly patient with COVID-19 complications: a clinical case
Tarantsova A.
PDF
(Rus)
编号 6 (2017)
CHANGES IN ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION ON THE BACKGROUND OF ANTICOAGULANT THERAPY AFTER CARDIOEMBOLIC STROKE IN PATIENTS WITH ATRIAL FIBRILLATION
Zolotovskaya I., Davydkin I.
PDF
(Rus)
编号 10 (2013)
Preduprezhdenie tromboembolii u bol'nykh fibrillyatsiey predserdiy
Kanorskiy S.
PDF
(Rus)
编号 11 (2009)
Influence of renin-angiotensin-aldosterone system blockade on atrial fibrillation course
Romanova E., Kirichenko A., Romanova E., Kirichenko A.
卷 30, 编号 14 (2023)
On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy
Ostroumova O., Dubinina A., De V., Kochetkov A., Dashabylova V., Eremina S., Klepikova M.
PDF
(Rus)
卷 28, 编号 13 (2021)
Antiarrhythmic therapy for atrial fibrillation in patients with the novel SARS-CoV-2 coronavirus infection: how to make the right choice?
Tarzimanova A., Bykova E.
PDF
(Rus)
编号 13 (2016)
ANTICOAGULATION WITH DIRECT ORAL ANTICOAGULANTS BEYOND CLINICAL RECOMMENDATIONS: DIFFICULT CHOICE OF CLINICIANS AND PERSONALIZED APPROACH TO TREATMENT
Napalkov D., Sokolova A.
PDF
(Rus)
编号 5 (2013)
AMIODARON I DISFUNKTsIYa ShchITOVIDNOY ZhELEZY
Pavlova T., Bulanova E., Duplyakov D.
PDF
(Rus)
编号 6 (2009)
role of sotalol in the treatment of heart rhythm disturbances: modern approaches
Sulimov V., Napalkov D., Sulimov V., Napalkov D.
卷 31, 编号 4 (2024)
Cognitive status of patients with coronary artery disease and concomitant atrial fibrillation
De V., Batyukina S., Kochetkov A., Klepikova M., Konik V., Ostroumova O.
PDF
(Rus)
卷 30, 编号 12 (2023)
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.
PDF
(Rus)
编号 6 (2016)
MANAGEMENT OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE SETTINGS OF ANTICOAGULANT THERAPY CONTROL OFFICE: PROLONGED EFFECTIVE AND SAFE USE OF ANTICOAGULATION
Sokolova A., Tsarev I., Napalkov D., Sulimov V.
PDF
(Rus)
编号 9 (2012)
N-3 POLINENASYShchENNYE ZhIRNYE KISLOTY V FARMAKOTERAPII FIBRILLYaTsII PREDSERDIY
Moiseev S.
PDF
(Rus)
卷 32, 编号 1 (2025)
Obesity and atrial fibrillation: new treatment options
Tarzimanova A., Valitova V., Speranskaya K., Samedova E., Okhtova A.
PDF
(Rus)
卷 31, 编号 4 (2024)
Pharmacotherapy of elderly multimorbid patients with atrial fibrillation in real clinical practice: practical application of STOPP/START criteria
Kochetkov A., Telkova S., Dubinina A., Mirzaev K., Shastina V., Cherniaeva M., Dashabylova V., Ostroumova O.
PDF
(Rus)
卷 30, 编号 9/10 (2023)
Modern treatment options for arrhythmias: focus on propafenone
Tarzimanova A.
PDF
(Rus)
卷 27, 编号 14 (2020)
Modern principles of maintaining sinus rhythm in atrial fibrillation
Tarzimanova A.
PDF
(Rus)
编号 13 (2014)
Novye oral'nye antikoagulyanty v profilaktike i lechenii venoznykh trombozov i tromboemboliy: fokus na rivaroksaban
Glezer M.
PDF
(Rus)
卷 32, 编号 1 (2025)
The diagnostic value of determining fibrosis biomarkers in patients with atrial fibrillation and coronary artery disease
Kochetkov A., Dubinina A., Gavrilova N., Korotkova T., Vorozhko I., Starodubova A., Mirzaev K., Ostroumova O.
PDF
(Rus)
卷 31, 编号 4 (2024)
Safety of direct oral anticoagulants in the treatment of atrial fibrillation in geriatric patients: focus on clinically relevant non-major bleeding
Sychev D., Cherniaeva M., Rozhkova M., Moiseeva E., Pogodina A., Bayzel Y., Egorova L., Maslennikova O., Lomakin N.
PDF
(Rus)
卷 30, 编号 1/2 (2023)
Possibilities of screening for asymptomatic atrial fibrillation in clinical practice
Stepanenko I., Sopova D., Salukhov V., Zaslavskaya E., Tarasov V., Novikov I.
PDF
(Rus)
卷 27, 编号 3 (2020)
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
Ostroumova O., Kochetkov A., Batyukina S., Lyakhova N.
PDF
(Rus)
编号 9 (2014)
PROFILAKTIKA TROMBOEMBOLIChESKIKh OSLOZhNENIY U PATsIENTOV S FIBRILLYaTsIEY PREDSERDIY
Morozova T., Andrushchishina T.
PDF
(Rus)
1 - 45 的 45 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语